Search clinical trials for: Aurora kinase inhibitor
Total 73411 results
-
National Cancer Institute (NCI)CompletedHilar Cholangiocarcinoma | Advanced Adult Hepatocellular Carcinoma | Localized Non-Resectable Adult Liver Carcinoma | Recurrent Adult Liver Carcinoma | Recurrent Gallbladder Carcinoma | Stage IV Distal Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Carcinoma | Stage II Gallbladder Cancer | Stage... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Merrimack PharmaceuticalsTerminatedColorectal Cancer | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
Onconova Therapeutics, Inc.CompletedHead and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cervical Squamous Cell Carcinoma | Skin Squamous Cell Carcinoma | Lung Squamous Cell Carcinoma | Penile Squamous Cell CarcinomaUnited States
-
Onconova Therapeutics, Inc.CompletedHead and Neck Neoplasms | Carcinoma, Squamous CellUnited States
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Italy, United Kingdom, Spain, Netherlands, Singapore, Germany, Hong Kong, Japan, France, Korea, Republic of, United States
-
GlaxoSmithKlineThe TIMI Study GroupCompletedAcute Coronary SyndromeUnited States, Australia, France, Spain, Taiwan, Estonia, Poland, Russian Federation, Belgium, Philippines, Sweden, Thailand, Germany, Israel, Bulgaria, Hong Kong, Netherlands, Norway, Slovakia, South Africa, Korea, Republic of, R... and more
-
Genentech, Inc.Terminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
PfizerCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, Spain, China, Brazil, United Kingdom, Japan, Poland, Australia, France, Ireland, Taiwan, Italy, Germany, Netherlands, Korea, Republic of, Bulgaria, Greece, Hong Kong, Hungary, Russian Federation, Sweden
-
PfizerCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, Spain, China, United Kingdom, Poland, France, Ireland, Japan, Taiwan, Germany, Netherlands, Italy, Brazil, Russian Federation, Korea, Republic of, Australia, Bulgaria, Greece, Hong Kong, Hungary, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Novartis PharmaceuticalsCompletedRenal Cell CarcinomaCanada, United Kingdom, Hong Kong, Netherlands, United States, Thailand, Korea, Republic of, Spain, Australia, Denmark, Mexico, Germany, Turkey, Italy, France, Brazil, Peru, Taiwan, Argentina
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung Cancer, Solid CancersUnited States, Netherlands
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Merrimack PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungSpain, Taiwan, United States, Canada, Korea, Republic of, Germany
-
Onconova Therapeutics, Inc.Academic GI Cancer Consortium (AGICC)CompletedMetastatic Pancreatic AdenocarcinomaUnited States, India, Russian Federation, Hungary, Ukraine
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal Tumor (GIST)China, South Africa, United States, France, Italy, United Kingdom, Germany, Taiwan, Turkey, Canada, Egypt, Singapore, Argentina, Austria, Poland, Russian Federation, Spain, Sweden, Thailand, Korea, Republic of, Bulgaria, Denmark, Japan and more
-
NSABP Foundation IncGlaxoSmithKlineUnknownInvasive Breast CancerUnited States, Canada, Puerto Rico
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIc MelanomaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell LymphomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedPulmonary Arterial HypertensionUnited States, Switzerland, Germany, Belgium, Spain, United Kingdom, Italy, Korea, Republic of, Netherlands, Canada, Sweden, Austria, Japan, France
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
Geron CorporationCompletedLocally Recurrent or Metastatic Breast CancerUnited States, Canada
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; Southwest Oncology... and other collaboratorsTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States, Canada
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IIIA Skin MelanomaUnited States, Australia
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Netherlands
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Merck Sharp & Dohme LLCTerminated
-
PfizerCompletedNeoplasms | Colorectal NeoplasmsUnited States
-
PfizerCompletedKidney TransplantationUnited States
-
Merck Sharp & Dohme LLCTerminatedColorectal Cancer | Advanced Solid Tumors
-
BayerAmgenCompletedMelanoma | CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
BayerCompletedCarcinoma, Renal CellRussian Federation, France, United States, Germany, Poland, Ukraine, United Kingdom
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
BayerCompletedCarcinoma, Renal CellUnited States, Canada